“`html
Haemonetics Corp. (Symbol: HAE) has seen its shares surpass the average 12-month analyst target price of $80.40, currently trading at $80.63 as of recent trading sessions. This movement prompts analysts to evaluate their target prices, with current projections ranging from a low of $62.00 to a high of $100.00, and an average of $80.40 with a standard deviation of $12.02.
There are a total of 10 analysts providing ratings for Haemonetics, showing 6 strong buy ratings, 2 buy ratings, and 3 hold ratings. The overall average rating stands at 1.73, indicating a general positive outlook, where 1 represents a strong buy and 5 a strong sell. Analyst sentiments often reflect recent business developments that could impact stock valuations.
“`
